These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4713345)

  • 1. Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
    Smith RB; Walsh PC; Goodwin WE
    J Urol; 1973 Jul; 110(1):106-8. PubMed ID: 4713345
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience in the treatment of prostatic carcinoma with cyproterone acetate.
    Wein AJ; Murphy JJ
    J Urol; 1973 Jan; 109(1):68-70. PubMed ID: 4684552
    [No Abstract]   [Full Text] [Related]  

  • 3. The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
    Goldenberg SL; Bruchovsky N; Rennie PS; Coppin CM
    J Urol; 1988 Dec; 140(6):1460-5. PubMed ID: 2973529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of prostatic carcinoma with cyproterone acetate.
    Tveter KJ; Otnes B; Hannestad R
    Scand J Urol Nephrol; 1978; 12(2):115-8. PubMed ID: 694435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cyproterone acetate on advanced carcinoma of the prostate.
    Geller J; Vazakas G; Fruchtman B; Newman H; Nakao K; Loh A
    Surg Gynecol Obstet; 1968 Oct; 127(4):748-58. PubMed ID: 5675191
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-androgenic therapy for prostate carcinoma].
    Schoonees R
    S Afr Med J; 1973 May; 47(17):722-4. PubMed ID: 4702294
    [No Abstract]   [Full Text] [Related]  

  • 7. Histochemical and biochemical investigation of advanced prostatic carcinoma treated with estramustine phosphate, Estracyt.
    Nilsson T; Müntzing J
    Scand J Urol Nephrol; 1973; 7(1):18-22. PubMed ID: 4701654
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proceedings: Value of cyproterone in the treatment of prostatic cancers with metastases].
    Bracci U
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):405-6. PubMed ID: 4804409
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate.
    Morales A; Burr RC; Bruce AW
    Can Med Assoc J; 1970 Aug; 103(4):372-3. PubMed ID: 5447717
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyproterone acetate. Its value in the treatment of prostatic cancer. Apropos of 45 cases].
    Tobelem G; Arvis G
    Therapie; 1988 May; 43(3):179-82. PubMed ID: 2971278
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver and kidney function following oral administration of the anti-androgen cyproteron-acetate].
    Burchardt P; Agrapidakis J
    Urologe A; 1972 Sep; 11(5):293-4. PubMed ID: 4562050
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenal suppression in the treatment of carcinoma of the prostate.
    Robinson MR; Shearer RJ; Fergusson JD
    Br J Urol; 1974 Oct; 46(5):555-9. PubMed ID: 4422260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognosis and treatment of prostatic carcinoma].
    Klug W
    Zentralbl Chir; 1968 Mar; 93(10):362-6. PubMed ID: 5674208
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of metastatic carcinoma of the prostate to bone with parathormone and radioactive phosphorous.
    Merrin C; Bakshi S
    J Surg Oncol; 1974; 6(1):67-72. PubMed ID: 4132074
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung metastases in prostatic carcinoma. Clinical significance.
    Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP
    Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
    Bhanalaph T; Varkarakis MJ; Murphy GP
    Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.
    Huggins C; Hodges CV
    CA Cancer J Clin; 1972; 22(4):232-40. PubMed ID: 4625049
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 19. Striking regression of advanced prostatic carcinoma induced by cyproterone acetate (Androcur). A case report.
    Varenhorst E; Björnlert U; Carlström K
    Scand J Urol Nephrol; 1981; 15(2):157-9. PubMed ID: 7330610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic adenocarcinoma of ductal origin.
    Dube VE; Farrow GM; Greene LF
    Cancer; 1973 Aug; 32(2):402-9. PubMed ID: 4124700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.